Search results
The FDA Should Reject MDMA Therapy—but Not for the Reasons You Think
Slate via Yahoo News· 2 hours agoFor example, in 2016 the FDA recommended that MAPS use an active compound (as opposed to an inactive...
Supreme Court upholds FDA's approval of abortion pills for early pregnancies
Los Angeles Times· 2 hours agoThe Supreme Court on Thursday dismissed a conservative Christian group’s claim that the abortion...
A Timeline of Céline Dion's Health Journey amid Her Stiff-Person Syndrome Diagnosis
People via Yahoo News· 5 hours agoDr. Amanda Piquet, the physician who diagnosed Dion, told PEOPLE the singer's treatments alone are a...
Senators decry lax e-cig enforcement | Northwest Arkansas Democrat-Gazette
Northwest Arkansas Democrat Gazette· 8 hours ago"I simply do not understand how FDA and DOJ have permitted thousands of products to remain on store...
Geron wins long-sought drug approval; Califf talks China, GLP-1s at BIO
BioPharma Dive via Yahoo Finance· 6 days agoAfter 34 years, Geron finally has an approved medicine in Rytelo. Elsewhere, Shionogi disclosed...
Senate hearing to spotlight illegal vaping companies that have dodged regulators
CW39 NewsFix· 1 day agoWASHINGTON (AP) — Health and law enforcement officials are set to face congressional questioning over the rise of illegal electronic cigarettes in the U.S., a multibillion-dollar business that has …
Regeneron, Sanofi Get Expanded FDA OK for Kevzara in Polyarticular Juvenile Idiopathic Arthritis
Morningstar· 2 days agoBy Colin Kellaher Regeneron Pharmaceuticals and Sanofi have won expanded Food and Drug Administration approval of their arthritis drug Kevzara for certain patients with a form of the disease that impacts multiple joints at a time. Regeneron
The Supreme Court just unanimously struck down a challenge to the abortion pill
Mother Jones· 2 hours agoFight disinformation: Sign up for the free Mother Jones Daily newsletter and follow the news that matters. When far-right activists won their decades-long crusade to overturn Roe v. Wade, they ...
Ipsen drug for rare liver disease approved by FDA
BioPharma Dive via Yahoo Finance· 2 days agoThe medicine will join Intercept’s Ocaliva as a treatment option for primary biliary cholangitis. Another drug, from the now Gilead-owned CymaBay, could...